Satish242 · Newsroom

Near Patient Molecular Solution Market Is Projected To Grow At A Moderate CAGR During The Period Of Assessment
Near patient molecular solution, also called point-of-care diagnosis, is a technology that helps diagnose and monitor health at the convenience of the patient.

January 16, 2019

Middle Ear Implants Market Present Chances, Trends, Value Chain And Stakeholder Analysis 2018-2026
Middle implant ear is a small device inserted into the middle ear and coupled to ossicles. Middle ear implants are devices designed for those who suffer mild- moderate mix or sensorineural hearing loss and conductive hearing loss.

January 7, 2019

Dengue Vaccines Market Size Growth Rate by Product Forecast 2026
Dengue is a mosquito-borne flavivirus debilitating disease with high prevalence in most tropical and sub-tropical regions.

January 4, 2019

Human Chorionic Gonadotropin (HCG) Market Analysis Showcases Growth Trends and Opportunity Forecast Until 2026
Human chorionic gonadotropin hormone (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus.

January 3, 2019

Contraceptives Drugs And Devices Market - Insights, Opportunity Analysis, and Industry Forecast till 2024
Intra-uterine devices (IUDs), vaginal rings, injectables, implants, combined oral contraceptives, and patches are some of the more advanced contraceptive methods available in the market.

December 24, 2018

Needle-free IV Connectors Market to 2026- Strategies, Applications and Competitive Landscape
Needle-Free IV Connectors are routinely used in the hospitals for intravenous administration of fluids and medicines to protect the hubs in vascular access systems.

December 6, 2018

Ablation Devices Market Expansion to be Persistent During 2026
Ablation is a form of minimally invasive surgery or laparoscopic surgery that is performed with the help of thin scopes and instruments referred to as ablation devices.

December 6, 2018

Contraceptives Drugs And Devices Market Demands and Growth Prediction 2018 to 2026
Contraceptive drugs and devices that aid to control birth rate and unintended pregnancies are subject to unique regulatory challenges across different countries.

November 5, 2018